THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT AND DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY OUTSIDE INDIA.

SSMD AGROTECH INDIA LIMITED

CIN: U10611DL2023PLC421046

Our company, SSMD Agrotech India Limited, operates its business under the name House Of Manohar. HOM - House Of Manohar is primarily involved in the manufacturing, trading and repacking of various FMCG products under the company owned various brands including Manohar Agro, Super S.S., Delhi Special and Shree Dhanlaxmi. The company manufactures products such as various varieties of Gram Flour, Chana Dal, Matar Flour, Puffed Rice, Ramdana and other agro food products. The company also manufactures Atta, Mustard Oil, Spices at its D2C Dark Store Factory. The company furthers repack a wide variety of other agro food products and sells it under the company owned brand. The company operates its sales network in both B2B and D2C market space.

House of Manohar follows a comprehensive business model that combines traditional distribution networks with modern consumer-focused solutions. The company aims to deliver quality food products to meet diverse customer needs while maintaining an efficient supply chain and utilizing advanced technology. The traditional business model relies on an extensive network of distributors across Delhi/NCR, Haryana, Uttar Pradesh, Punjab, and Uttarakhand, which ensures effective distribution, broad market reach, and increased product visibility.

To adapt to changing consumer preferences, House of Manohar has introduced a Direct-to-Consumer model, supported by innovative dark store factories. This initiative focuses on delivering fresh and quality products, such as atta, oil, and spices, directly to customers within 10 minutes. This model aims to improve convenience, maintain product quality, and strengthen customer trust in the brand.

For Further details, please refer Chapter titled "Business Overview" beginning on Page no. 145 of this Prospectus.

Return on Net Worth (RoNW) as per restated financial statements

The KPIs disclosed below have been used historically by SSMD Agrotech India Limited (formerly SSMD Agrotech India Private Limited) the Company to understand and analyze the business performance, which in result, help the company in analyzing the growth of various verticals in comparison to the company's peers. The KPIs disclosed below have been approved by a resolution of the Audit Committee dated October 27th, 2025 and the members of the Audit Committee have verified the details of all KPIs pertaining to the Company. Further, the members of the Audit Committee have confirmed that there are no KPIs pertaining to the Company that have been disclosed to any investors at any point of time during the since incorporation of the company prior to the date of filing of the Prospectus.

Our Company confirms that it shall continue to disclose all the KPIs included in this section on a periodic basis, at least once in a year(or any lesser period as determined by the Board of our Company), for a duration of one year after the date of listing of the Equity Shares on the Stock Exchange or till the complete utilisation of the proceeds of the Fresh Issue as per the disclosure made in the Objects of the Issue Section, whichever is later or for such other duration as may be required under the SEBI ICDR Regulations. Further, the ongoing KPIs will continue to be certified by a member of an expert body as required under the SEBI ICDR Regulations.

The KPIs disclosed below have been approved by a resolution of our Audit Committee dated July 01, 2025 and the members of the Audit Committee have verified the details of all KPIs pertaining to the Company. Further, the members of the Audit Committee have confirmed that there are no KPIs pertaining to our Company that have been disclosed to any investors at any point of time since Incorporation to the date of filing of the Prospectus. Further, the KPIs herein have been certified by statutory auditor.

(17) Current Ratio is calculated by dividing Current assets to Current Liabilities

As certified by Statutory and Peer Review Auditor, M/s Chanana and Associates, Chartered Accountant vide certificate dated October 27th, 2025 having UDIN- 25530041BMLGX11766.

The Weighted average cost of acquisition of Equity shares on the basis of primary / new issue of shares (equity/convertible securities), excluding shares issued under ESOP/ESOS and issuance of bonus shares, during the 18 months preceding the date of filing of the Prospectus, where such issuance is equal to or more than 5 per cent of the fully diluted paid-up share capital of the Issuer Company (calculated based on the pre-issue capital before such transaction/s and excluding employee stock options granted but not vested), in a single transaction or multiple transactions combined together over a span of rolling 30 days:

B. The Weighted average cost of acquisition of Equity shares secondary sale / acquisitions of Equity Shares, where the promoters, members of the promoter group or shareholder(s) having the right to nominate director(s) in the board of directors of the Company are a party to the transaction (excluding gifts), during the 18 months preceding the date of this certificate, where either acquisition or sale is equal to or more than 5% of the fully diluted paid up share capital of the Company (calculated based on the pre-issue capital before such transaction's and excluding employee stock options granted but not vested), in a single transaction or multiple transactions combined together over a span of rolling 30 days-

As certified by M/s Chanana & Associates, Chartered Accountants, by way of their certificate dated October 27, 2025 dated UDIN: 25530041BMLGXL3157

The face value of Equity Shares of our Company is Rs. 10 per Equity Share and the Issue Price of Rs. 121 /- per Equity Share is 12.1 times of the face value.

Investors should read the above-mentioned information along with section titled "Business Overview", "Risk Factors" and "Financial Information of our Company" beginning on page 145, 32 and 217 respectively including important profitability and return ratios, as set out in chapter titled "Other Financial Information" on page 288 of this Prospectus to have a more inform vie

This Issue is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulations, wherein not more than 50.00% of the Net Issue shall be available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company may, in consultation with the Book Running Lead Manager, may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations ("Anchor Investor Portion"), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the Net QIB Portion. Further, 5.00% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, the SEBI ICDR Regulations read with SEBI ICDR (Amendment) Regulations, 2025, states that not less than 35% of the Net Issue shall be available for allocation to Individual Investors who applies for minimum application size. Not less than 15% of the Net Issue shall be available for allocation to Non-Institutional Investors of which one-third of the Non-Institutional Portion will be available for allocation to Bidders with an application size of more than two lots and up to such lots as equivalent to not more than Rs. 10.00 Lakhs and two-thirds of the Non-Institutional Portion will be available for allocation to Bidders with an application size of more than Rs. 10.00 Lakhs and under-subscription in either of these two sub-categories of Non-Institutional Portion may be allocated to Bidders in the other sub-category of Non-Institutional Portion. Subject to the availability of shares in non-institutional investors' category, the allotment to each Non-Institutional Investors shall not be less than the minimum application size in Non-Institutional Category and the remaining available Equity Shares, if any, shall be allocated on a proportionate basis in accordance with the conditions specified in this regard in Schedule XIII of the SEBI (ICDR) (Amendment) Regulations, 2025. All Bidders are required to participate in the Issue by mandatorily utilizing the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts will be blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Issue through the ASBA process. For details, see "Issue Procedure" on page No: 242 of this Prospectus. The investors are advised to refer to the Prospectus for the full text of the Disclaimer Clause of the BSE Limited of BSE. For the purpose of this Issue, the designated Stock Exchange will be the Bombay Stock Exchange of India Limited (BSE SME). The trading is proposed to be commenced on or before December 2, 2025*

*Subject to the receipt of listing and trading approval from the Bombay Stock Exchange.

The Issue was opened on Tuesday, November 25, 2025 and Closed on Thursday, November 27, 2025. The Issue was made as per the Book Building Process. However, the Company in consultation with the BRLM has decided that no participation by the anchor investors will be considered in the IPO. The Issue received 2,019 applications for 47,49,000 Equity Shares (before technical rejections and after invalid bids Multiple/Duplicate/bids (UPI Mandates) not accepted by investors, / blocked, bids rejected under application banked but bid not registered) resulting in 1.69 times subscription (including reserved portion of market maker).

The 6,90,000 equity shares spilled over from NII2 category to NII1, QIB & Individual Investor categories, Since sufficient balance is not available in the NII1 category, only 1,73,000 additional shares allotted in the NII1 category and balance from NII2 category spilled over to QIB & Individual investor category.

A summary of the final demand as per BSE as on the Bid/Issue Closing Date at different Bid prices is as under:

The Basis of Allotment was finalised in consultation with the Designated Stock Exchange, being Bombay Stock Exchange Limited ("BSE SME") on November 28, 2025.

The Basis of Allotment to the Individual Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 121/- per Equity Share, was finalized in consultation with Bombay Stock Exchange Limited ("BSE SME"). The category has been subscribed to the extent of 1.62 times. The total number of Equity Shares Allotted in this category is 18,24,000 Equity Shares to 912 successful applicants. The details of the Basis of Allotment of the said category are as under:

The Basis of Allotment to the Non-Institutional Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 121/- per Equity Share, was finalized in consultation with Bombay Stock Exchange Limited ("BSE SME"). The category has been subscribed to the extent of 1.00 times. The total number of Equity Shares Allotted in this category is 6,12,000 Equity Shares to 194 successful applicants. The details of the Basis of Allotment of the said category is as under:

The Basis of Allotment to the Non-Institutional Investors, who have Bid at cut-off Price or at or above the Issue Price of Rs. 121/- per Equity Share, was finalized in consultation with Bombay Stock Exchange Limited ("BSE SME"). The category has been subscribed to the extent of 0.21 times. The total number of Equity Shares Allotted in this category is 1,87,000 Equity Shares to 11 successful applicants. The details of the Basis of Allotment of the said category are as under:

Allotment to QIBs, who have bid at the Issue Price of Rs. 121/- per Equity Share or above, has been done on a proportionate basis in consultation with Bombay Stock Exchange Limited ("BSE SME"). This category has been subscribed to the extent of 3.79 times of QIB portion. As per the SEBI Regulations, Mutual Funds were Allotted 5% of the Equity Shares of QIB Portion available i.e., NIL Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e., 47000 Equity Shares on a proportionate basis. The total number of Equity Shares Allotted in the QIB Portion is 38,000 Equity Shares which were allotted to 3 successful QIB Investors. The category-wise details of the Basis of Allotment are as under:

5) Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to Market Maker who have bid at Issue Price of Rs. 121/- per Equity Shares or above, was finalized in consultation with Bombay Stock Exchange Limited ("BSE SME"). The category was subscribed 1.00 times i.e. for 1,56,000 Equity Shares the total number of shares allotted in this category is 1,56,000 Equity Shares. The category wise details of the Basis of Allotment are as under:

The Board of Directors of our Company at its meeting held on November 28, 2025 has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being Bombay Stock Exchange Limited and has allotted the Equity Shares to various successful applicants. The Allotment Advice Cum Refund Intimation will be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched/ mailed for unblocking of funds and transfer to the Public Issue Account on or before December 1, 2025 and payment to non-Syndicate brokers have been issued on December 1, 2025. In case the same is not received within ten days, investors may contact the Registrar to the Issue at the address given below. The Equity Shares allotted to the successful allottees shall be uploaded on or before December 1, 2025 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is in the process of obtaining the listing and trading approval from Bombay Stock Exchange Limited ("BSE SME") and the trading of the Equity Shares is expected to commence on December 2, 2025.

Note: All capitalized terms used and not defined herein shall have the respective meaning assigned to them in the Prospectus dated November 28, 2025 ("Prospectus").

The details of the allotment made would also be hosted on the website of the Registrar to the Issue, BIGSHARE SERVICES PRIVATE LIMITED: www.bigshareonline.com

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

Disclaimer: SSMD AGROTECH INDIA LIMITED (is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the Prospectus with the Registrar of Companies, Delhi, November 28, 2025 and thereafter with SEBI and the Stock Exchange. The Prospectus is available on the website of BSE SME at https://www.bsesme.com/Publiclssues/ and is available on the websites of the BRLM at www.3dcsl.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the Prospectus including the section titled "Risk Factors" beginning on page No: 32 of the Prospectus.

The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended or any state securities laws in the United States, and unless so registered, and may not be issued or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, 1933 and in accordance with any applicable U.S. State Securities laws. The Equity Shares are being issued and sold outside the United States in 'offshore transactions' in reliance on Regulation "S" under the Securities Act, 1933 and the applicable laws of each jurisdiction where such issues and sales are made. There will be no public offering in the United States.